Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Biol Macromol ; 98: 357-365, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28130137

RESUMO

The present work deals with investigating the role of ionic interactions in the native conformation of BmGK by altering pH and salt concentration as well as by disruption of inter-subunit region. The study on structural and functional properties of BmGK as a function of pH showed that the secondary and tertiary elements of the protein were disturbed at low pH with loss of its native oligomerization and functional activity. High concentration of NaCl also changed the native conformation of BmGK with dissociation of its dimeric form. We also mutated dimeric interface of BmGK and identified intersubunit residues, Arg105 and Glu140, essential for dimer stability as double mutation at both positions hinders dimerization. The quaternary structure is found to be essential for full enzymatic activity and stability. In vitro results were supported by in silico molecular dynamics simulation studies through conformational stability analysis. Thus, the work carried out points toward new approach of targeting dimeric interface of BmGK in lieu of its similar active site region to its counterpart human enzyme. This may lead to the design of inhibitors targeted to key parasitic enzyme (BmGK) specifically.


Assuntos
Brugia Malayi/enzimologia , Guanilato Quinases/química , Guanilato Quinases/metabolismo , Animais , Relação Dose-Resposta a Droga , Estabilidade Enzimática/efeitos dos fármacos , Guanilato Quinases/genética , Concentração de Íons de Hidrogênio , Simulação de Dinâmica Molecular , Mutagênese Sítio-Dirigida , Mutação , Concentração Osmolar , Multimerização Proteica/efeitos dos fármacos , Estrutura Quaternária de Proteína/efeitos dos fármacos , Estrutura Secundária de Proteína/efeitos dos fármacos , Cloreto de Sódio/farmacologia
2.
Int J Biol Macromol ; 94(Pt A): 621-633, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27751808

RESUMO

Guanylate kinase is one of the key enzymes in nucleotide biosynthesis. The study highlights the structural and functional properties of Brugia malayi Guanylate kinase (BmGK) in the presence of chemical denaturants. An inactive, partially unfolded, dimeric intermediate was observed at 1-2M urea while GdnCl unfolding showed monomer molten globule like intermediate at 0.8-1.0M. The results also illustrate the protective role of substrates in maintaining the integrity of the enzyme. The thermo stability of protein was found to be significantly enhanced in the presence of the substrates. Furthermore, binding of the substrates, GMP and ATP to BmGK changed its GdnCl induced unfolding pattern. Docking and molecular dynamic simulation performed for native BmGK, BmGK bound to GMP and GMP+ATP showed change in the fluctuation in the region between 130 and 150 residues. Arg134 lost its interaction with GMP and Arg145 interaction shifted to ATP after 40ns simulation upon binding of ATP to BmGK-GMP complex. We, thus, propose the importance of specific rearrangements contributed by binding of substrates which participate in the overall stability of the protein. The work here emphasizes on detailed biophysical characterization of BmGK along with the significant role of substrates in modulating the structural and functional properties of BmGK.


Assuntos
Trifosfato de Adenosina/química , Brugia Malayi/química , Guanosina Monofosfato/química , Guanilato Quinases/química , Proteínas de Helminto/química , Animais , Brugia Malayi/enzimologia , Reagentes de Ligações Cruzadas/química , Escherichia coli/genética , Escherichia coli/metabolismo , Expressão Gênica , Glutaral/química , Guanidina/química , Guanilato Quinases/genética , Guanilato Quinases/metabolismo , Proteínas de Helminto/genética , Proteínas de Helminto/metabolismo , Simulação de Acoplamento Molecular , Ligação Proteica , Desnaturação Proteica , Dobramento de Proteína , Estrutura Secundária de Proteína , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Ureia/química
3.
J Basic Clin Physiol Pharmacol ; 27(2): 121-9, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26490091

RESUMO

BACKGROUND: Flacourtia indica (Burm. f.) Merr. is a medicinal plant indigenous to India and is broadly used worldwide for the treatment of a variety of health ailments. The present study was experimented on hyperlipidemic Charles Foster rats with the aim to explore the possible mechanism responsible for the antidyslipidemic activity of the hydromethanolic extract from F. indica leaves (FIL). METHODS: Hyperlipidemia was induced by a single intraperitoneal dose of Triton WR-1339 in Charles Foster rats. The plasma lipid levels were estimated in control and treated groups. The antioxidant potential of F. indica was assessed in both enzymatic and non-enzymatic systems. An acute toxicity study of high-performance liquid chromatography (HPLC)-fingerprinted extract was carried out in Swiss albino mice. RESULTS: The F. indica extract at a dose of 150 mg/kg significantly lowers the plasma level of total cholesterol (17%), triglycerides (13%), and phospholipids (16%) by increasing post-heparin lipolytic activity (19%) and lecithin-cholesterol-acyltransferase activity (20%) in Triton-induced hyperlipidemic rats. In addition, the F. indica extract showed significant in vitro antioxidant and anti-adipogenic activity. HPLC analysis indicates the presence of flavanones and flavones in the extract, and the extract was found to be non-toxic up to a dose of 2000 mg/kg body weight in the acute oral toxicity study. CONCLUSIONS: These finding suggest that F. indica holds significant potential in preventing clinical deterioration induced by dyslipidemia along with oxidative stress.


Assuntos
Dislipidemias/tratamento farmacológico , Hiperlipidemias/tratamento farmacológico , Hipolipemiantes/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/farmacologia , Salicaceae/química , Animais , Antioxidantes/metabolismo , Colesterol/sangue , Modelos Animais de Doenças , Dislipidemias/sangue , Flavanonas/farmacologia , Flavonas/farmacologia , Hipoglicemiantes/farmacologia , Masculino , Camundongos , Folhas de Planta/química , Plantas Medicinais/química , Ratos , Triglicerídeos/sangue
4.
Parasitol Int ; 64(6): 579-86, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26281757

RESUMO

Chitin metabolism has been shown to have a role in the development of parasitic nematodes including filarial parasites and the enzymes associated with chitin metabolism have been considered as potential vaccine and drug target. Chitinases are members of the enzyme superfamily of glycoside hydrolases, which are characterized by the ability to hydrolyze glycosidic bonds in chitin chain by either an endolytic or an exolytic mechanism. In the present study, we have demonstrated the chitinase (exochitinase and endochitinase) activity in different stages of Setaria cervi (bovine filarial parasite) and have also purified and characterized the endochitinase from microfilarial stage of the parasite. The chitinase activity has been detected in adult and microfilarial stages of S. cervi using the fluorescent substrates. The S. cervi adult stage was found to have high activity of exochitinase (28.72±0.25 nmol/min/mg) while microfilarial stage showed high activity of endochitinase (24.40±0.25 nmol/min/mg). Native polyacrylamide gel electrophoresis, followed by staining of enzyme activity with fluorescent substrates, revealed single isoenzymic form of exochitinase in adults and endochitinase in microfilariae of S. cervi. The endochitinase from S. cervi microfilariae was purified employing chitin affinity matrix and DEAE-Sephacel ion-exchange chromatography. The enzyme was purified about 55 fold with an enzyme recovery of 22.33%. The purified enzyme exhibited a doublet of protein bands on SDS-PAGE at 65-70 kDa. The closantel (chitinase inhibitor) strongly inhibited the enzyme activity of S. cervi microfilariae endochitinase with a Ki value of 4.3±0.18 µM.


Assuntos
Quitina/metabolismo , Quitinases/metabolismo , Hexosaminidases/metabolismo , Setaria (Nematoide)/enzimologia , Animais , Quitinases/antagonistas & inibidores , Eletroforese em Gel de Poliacrilamida , Hexosaminidases/antagonistas & inibidores , Microfilárias/enzimologia , Microfilárias/metabolismo , Salicilanilidas/metabolismo , Setaria (Nematoide)/crescimento & desenvolvimento , Setaria (Nematoide)/metabolismo
5.
Parasitology ; 141(10): 1341-52, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25061727

RESUMO

Guanylate kinase, a nucleoside monophosphate kinase of Brugia malayi which is involved in reversible transfer of phosphate groups from ATP to GMP, was cloned, expressed and characterized. The native molecular mass of BmGK was found to be 45 kDa as determined by size exclusion chromatography and glutaraldehyde cross-linking which revealed that the protein is homodimer in nature. This is a unique characteristic among known eukaryotic GKs. GMP and ATP served as the most effective phosphate acceptor and donor, respectively. Recombinant BmGK utilized both GMP and dGMP, as substrates showing Km values of 30 and 38 µ m, respectively. Free Mg+2 (un-complexed to ATP) and GTP play a regulatory role in catalysis of BmGK. The enzyme showed higher catalytic efficiency as compared with human GK and showed ternary complex (BmGK-GMP-ATP) formation with sequential substrate binding. The secondary structure of BmGK consisted of 45% α-helices, 18% ß-sheets as revealed by CD analysis. Homology modelling and docking with GMP revealed conserved substrate binding residues with slight differences. Differences in kinetic properties and oligomerization of BmGK compared with human GK can provide the way for design of parasite-specific inhibitors.


Assuntos
Filariose/parasitologia , Guanilato Quinases/metabolismo , Núcleosídeo-Fosfato Quinase/metabolismo , Animais , Brugia Malayi/genética , Dimerização , Guanilato Quinases/genética , Guanilato Quinases/isolamento & purificação , Humanos , Cinética , Modelos Moleculares , Peso Molecular , Núcleosídeo-Fosfato Quinase/genética , Núcleosídeo-Fosfato Quinase/isolamento & purificação
6.
J Med Chem ; 57(8): 3342-57, 2014 Apr 24.
Artigo em Inglês | MEDLINE | ID: mdl-24635539

RESUMO

Antileishmanial activities of a library of synthetic chalcone analogues have been examined. Among them, five compounds (11, 14, 16, 17, 22, and 24) exhibited better activity than the marketed drug miltefosine in in vitro studies against the intracellular amastigotes form of Leishmania donovani. Three promising compounds, 16, 17, and 22, were tested in a L. donovani/hamster model. Oral administration of chalcone 16, at a concentration of 100 mg/kg of body weight per day for 5 consecutive days, resulted in >84% parasite inhibition at day 7 post-treatment and it retained the activity until day 28. The molecular and immunological studies revealed that compound 16 has a dual nature to act as a direct parasite killing agent and as a host immunostimulant. Pharmacokinetics and serum albumin binding studies also suggest that compound 16 has the potential to be a candidate for the treatment of the nonhealing form of leishmaniasis.


Assuntos
Antiprotozoários/síntese química , Chalconas/síntese química , Leishmania donovani/efeitos dos fármacos , Animais , Antiprotozoários/farmacocinética , Antiprotozoários/farmacologia , Chalconas/farmacocinética , Chalconas/farmacologia , Cricetinae , Citocinas/biossíntese , Estabilidade de Medicamentos , Macrófagos/imunologia , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Mesocricetus , Óxido Nítrico/biossíntese , Relação Estrutura-Atividade
7.
Chem Biol Drug Des ; 84(2): 175-81, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24444074

RESUMO

A series of novel 4-aminoquinolinyl and 9-anilinoacridinyl Schiff base hydrazones have been synthesized and evaluated for their antimalarial activity. All compounds were evaluated in vitro for their antimalarial activity against chloroquine-sensitive strain 3D7 and the chloroquine-resistant K1 strain of Plasmodium falciparum and for cytotoxicity toward Vero cells. Compounds 17, 20, and 21 displayed good activity against the 3D7 strain with IC50 values ranging from 19.69 to 25.38 nm. Moreover, compounds 16, 17, 21, 24, 32, and 33 exhibited excellent activities (21.64-54.26 nm) against K1 strain and several compounds displayed ß-hematin inhibitory activity, suggesting that they act on the heme crystallization process such as CQ. Compounds were also found to be non-toxic with good selectivity index.


Assuntos
Acridinas/química , Acridinas/farmacologia , Aminoquinolinas/química , Aminoquinolinas/farmacologia , Antimaláricos/química , Antimaláricos/farmacologia , Plasmodium falciparum/efeitos dos fármacos , Animais , Chlorocebus aethiops , Hidrazonas/química , Hidrazonas/farmacologia , Malária Falciparum/tratamento farmacológico , Masculino , Camundongos , Bases de Schiff/química , Bases de Schiff/farmacologia , Células Vero
8.
Behav Pharmacol ; 24(4): 307-19, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23838966

RESUMO

This study evaluated the effects of a standardized ethyl acetate extract of Morinda citrifolia L. (Noni) fruit on impairment of memory, brain energy metabolism, and cholinergic function in intracerebral streptozotocin (STZ)-treated mice. STZ (0.5 mg/kg) was administered twice at an interval of 48 h. Noni (50 and 100 mg/kg, postoperatively) was administered for 21 days following STZ administration. Memory function was evaluated using Morris Water Maze and passive avoidance tests, and brain levels of cholinergic function, oxidative stress, energy metabolism, and brain-derived neurotrophic factor (BDNF) were estimated. STZ caused memory impairment in Morris Water Maze and passive avoidance tests along with reduced brain levels of ATP, BDNF, and acetylcholine and increased acetylcholinesterase activity and oxidative stress. Treatment with Noni extract (100 mg/kg) prevented the STZ-induced memory impairment in both behavioral tests along with reduced oxidative stress and acetylcholinesterase activity, and increased brain levels of BDNF, acetylcholine, and ATP level. The study shows the beneficial effects of Noni fruit against STZ-induced memory impairment, which may be attributed to improved brain energy metabolism, cholinergic neurotransmission, BDNF, and antioxidative action.


Assuntos
Transtornos da Memória/tratamento farmacológico , Morinda , Fitoterapia/métodos , Extratos Vegetais/uso terapêutico , Acetilcolina/metabolismo , Acetilcolinesterase/genética , Acetilcolinesterase/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Antibióticos Antineoplásicos/toxicidade , Aprendizagem da Esquiva/efeitos dos fármacos , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Encéfalo/patologia , Fator Neurotrófico Derivado do Encéfalo/genética , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Cromatografia Líquida de Alta Pressão , Modelos Animais de Doenças , Glutationa/metabolismo , Injeções Intraventriculares , Masculino , Malondialdeído/metabolismo , Aprendizagem em Labirinto/efeitos dos fármacos , Transtornos da Memória/induzido quimicamente , Camundongos , Atividade Motora/efeitos dos fármacos , Nitritos/metabolismo , Extratos Vegetais/química , Polifenóis/uso terapêutico , RNA Mensageiro/metabolismo , Tempo de Reação/efeitos dos fármacos , Estreptozocina/toxicidade
9.
J Med Chem ; 56(11): 4374-92, 2013 Jun 13.
Artigo em Inglês | MEDLINE | ID: mdl-23611626

RESUMO

The high potential of quinazolinone containing natural products and their derivatives in medicinal chemistry led us to discover four novel series of 53 compounds of quinazolinone based on the concept of molecular hybridization. Most of the synthesized analogues exhibited potent leishmanicidal activity against intracellular amastigotes (IC50 from 0.65 ± 0.2 to 7.76 ± 2.1 µM) as compared to miltefosine (IC50 = 8.4 ± 2.1 µM) and nontoxic toward the J-774A.1 cell line and Vero cells. Moreover, activation of Th1 type and suppression of Th2 type immune responses and induction in nitric oxide generation proved that 8a and 8g induce murine macrophages to prevent survival of parasites. Compounds 8a and 8g exhibited significant in vivo inhibition of parasite 73.15 ± 12.69% and 80.93 ± 10.50% against Leishmania donovani /hamster model. Our results indicate that compounds 8a, 8g, and 9f represent a new structural lead for this serious and neglected disease.


Assuntos
Antiparasitários/síntese química , Produtos Biológicos/química , Leishmania donovani/efeitos dos fármacos , Quinazolinonas/síntese química , Animais , Antiparasitários/farmacocinética , Antiparasitários/farmacologia , Bovinos , Linhagem Celular , Chlorocebus aethiops , Cricetinae , Citocinas/metabolismo , Feminino , Leishmaniose Visceral/tratamento farmacológico , Leishmaniose Visceral/parasitologia , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Macrófagos/parasitologia , Masculino , Mesocricetus , Camundongos , Óxido Nítrico/metabolismo , Testes de Sensibilidade Parasitária , Quinazolinonas/farmacocinética , Quinazolinonas/farmacologia , Ratos , Ratos Sprague-Dawley , Soroalbumina Bovina/química , Relação Estrutura-Atividade
10.
Acta Trop ; 127(2): 82-6, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23603670

RESUMO

We recently reported that BmAFI, an anti-inflammatory fraction of Brugia malayi adult worm supports parasite development in the hostile peritoneal cavity (p.c.) of Mastomys coucha through a modified Th2 type of response that includes IL-13 and IgE response and anti-inflammatory IL-10 cytokine milieu. In the present study we investigated IgE related responses such as histamine release and modulation of histamine receptors 1 and 2 (HR1 and HR2) by presensitization with BmAFI of M. coucha infected with B. malayi. Sensitization with BmAFI alone enhanced IgE, histamine and HR2, but decreased HR1. Exposure of these animals to infection produced an IgE response that was inversely related to the parasite burden, and decreased histamine conc., and HR1 and HR2 expression. However, there was an early small increase in HR1 expression for a short period after exposure to infection. As expected, BmAFI sensitization supported parasite survival and development in the hostile p.c. of the host. These findings further establish that BmAFI decreases inflammatory/Th1 response and modulates Th2 responses to favour survival and development of the parasite in the hostile p.c. of the host and that IgE and histamine play an important role in this.


Assuntos
Brugia Malayi/metabolismo , Filariose/veterinária , Proteínas de Helminto/farmacologia , Histamina/metabolismo , Imunoglobulina E/metabolismo , Murinae , Receptores Histamínicos/metabolismo , Animais , Anti-Inflamatórios , Brugia Malayi/química , Masculino , Receptores Histamínicos/genética
11.
Parasitology ; 140(7): 897-906, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23506961

RESUMO

Glucose-6-phosphate dehydrogenase (G6PD), a regulatory enzyme of the pentose phosphate pathway from Brugia malayi, was cloned, expressed and biochemically characterized. The Km values for glucose-6-phosphate and nicotinamide adenine dinucleotide phosphate (NADP) were 0.25 and 0.014 mm respectively. The rBmG6PD exhibited an optimum pH of 8.5 and temperature, 40 °C. Adenosine 5' [γ-thio] triphosphate (ATP-γ-S), adenosine 5' [ß,γ-imido] triphosphate (ATP-ß,γ-NH), adenosine 5' [ß-thio] diphosphate (ADP-ß-S), Na+, K+, Li+ and Cu++ ions were found to be strong inhibitors of rBmG6PD. The rBmG6PD, a tetramer with subunit molecular weight of 75 kDa contains 0.02 mol of SH group per mol of monomer. Blocking the SH group with SH-inhibitors, led to activation of rBmG6PD activity by N-ethylmaleimide. CD analysis indicated that rBmG6PD is composed of 37% α-helices and 26% ß-sheets. The unfolding equilibrium of rBmG6PD with GdmCl/urea showed the triphasic unfolding pattern along with the highly stable intermediate obtained by GdmCl.


Assuntos
Brugia Malayi/enzimologia , Glucosefosfato Desidrogenase/química , Glucosefosfato Desidrogenase/genética , Animais , Western Blotting , Brugia Malayi/genética , Clonagem Molecular , Filariose Linfática/tratamento farmacológico , Glucosefosfato Desidrogenase/metabolismo , Cinética , NADP/metabolismo , RNA de Helmintos/química , RNA de Helmintos/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase Reversa
12.
J Cardiovasc Pharmacol ; 61(6): 505-12, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23429594

RESUMO

: Alcoholic extract of Trigonella foenum graecum seeds [fenugreek seed extract (FSE)] was studied in triton-induced and high-fat diet-induced hyperlipidemia to evaluate antidyslipidemic effect. Plasma cholesterol (26.19%) and triglycerides (36.6%) were found to be lowered by FSE maximum at a dose of 200 mg/kg body weight in triton-treated hyperlipidemic rats. Chronic feeding of FSE (200 mg/kg body weight) caused lowering in plasma and hepatic lipid levels by activating lecithin-cholesterol acyltransferase (47%), postheparin lipolytic activity (35%), triglyceride lipase (34%), lipoprotein lipase (20.8%), and increased excretion of fecal bile acids (36%-45%). The FSE shows potent antioxidant activity in both in vitro and in vivo systems. It inhibited generation of superoxide anion and hydroxyl free radicals in both enzymatic and nonenzymatic systems significantly at 200 µM concentration. Furthermore, FSE normalizes the activities of antioxidant enzymes, that is, superoxide dismutase and catalase, and reduces plasma lipid peroxidation (33.9%), hepatic 4-hydroxynonenal (27%), and isoprostanes (28%). Data of the present study demonstrated that the T. foenum graecum seed extract has both antidyslipidemic and antioxidant properties.


Assuntos
Antioxidantes/farmacologia , Dislipidemias/prevenção & controle , Hiperlipidemias/prevenção & controle , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/farmacologia , Trigonella/química , Animais , Ácidos e Sais Biliares/metabolismo , Colesterol/sangue , Modelos Animais de Doenças , Técnicas In Vitro , Lipase Lipoproteica/metabolismo , Masculino , Fosfatidilcolina-Esterol O-Aciltransferase/metabolismo , Ratos , Sementes/química , Resultado do Tratamento , Triglicerídeos/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...